Thilo Schroeder, Director at Revolution Medicines, Inc. (RVMD), bought 434,336 shares at $18.91 ($8.2M) on 2022-03-07, disclosed to the SEC on 2022-03-09.
Open-market purchase of $8.2M RVMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.35 | 95,926 | $1.8M | 21.6% |
| 2 | $18.35 | 95,926 | $1.8M | 21.6% |
| 3 | $18.91 | 7,079 | $134K | 1.6% |
| 4 | $18.91 | 7,079 | $134K | 1.6% |
| 5 | $18.23 | 42,882 | $782K | 9.6% |
| 6 | $18.23 | 42,882 |
| $782K |
| 9.6% |
| 7 | $19.36 | 42,011 | $813K | 10.0% |
| 8 | $19.36 | 42,011 | $813K | 10.0% |
| 9 | $19.90 | 18,940 | $377K | 4.6% |
| 10 | $20.07 | 39,600 | $795K | 9.8% |
| Total | $18.76 avg | 434,336 | $8.2M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-26 | $5.0M | — | Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |